Ligand profile
MJU
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00051 — DNA gyrase subunit B
Identifiers
Database identifiers and provenance.
- Ligand ID
MJU- PDB
4ktn- UniProt (similar protein)
Q839Z1- Target protein
- KP13_00051
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 109.5
- −1 ≤ LogP ≤ 5 3.14
- MW ≤ 500 Da 414.5
- LogP ≤ 5 3.14
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 109.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc2c(c1)c3c([nH]2)nc(nc3N4CC[C@@H](C4)N)Sc5cc6c(nccn6)nc5c1ccc2c(c1)c3c([nH]2)nc(nc3N4CC[C@@H](C4)N)Sc5cc6c(nccn6)nc5
InChI=1S/C21H18N8S/c22-12-5-8-29(11-12)20-17-14-3-1-2-4-15(14)26-19(17)27-21(28-20)30-13-9-16-18(25-10-13)24-7-6-23-16/h1-4,6-7,9-10,12H,5,8,11,22H2,(H,26,27,28)/t12-/m0/s1InChI=1S/C21H18N8S/c22-12-5-8-29(11-12)20-17-14-3-1-2-4-15(14)26-19(17)27-21(28-20)30-13-9-16-18(25-10-13)24-7-6-23-16/h1-4,6-7,9-10,12H,5,8,11,22H2,(H,26,27,28)/t12-/m0/s1
YQQNXOBXIZYKPR-LBPRGKRZSA-NYQQNXOBXIZYKPR-LBPRGKRZSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02518
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand MJU →
- PDB RCSB structure 4ktn →
- UniProt UniProt Q839Z1 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “MJU”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00051.
PDB 87
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).